Review: could Myelodysplastic syndrome cause Enlarged spleen?
This is a review of Enlarged spleen (Splenomegaly) among 11,721 people who have Myelodysplastic syndrome. We analyze the Myelodysplastic syndrome patients by their gender and age, drugs used, and common conditions other than Myelodysplastic syndrome. The review is created by eHealthMe based on reports from FDA and is updated regularly.
For patients like me, how are my drugs? On eHealthMe, you can research 300 million drug outcomes from FDA and social media. We use data reported since 1977 till to date. All studies are personalized to gender and age. Start now >>>
Enlarged spleen (enlargement of spleen) (latest reports from 37,840 patients) has been reported by people with rheumatoid arthritis, hiv infection, high blood pressure, hepatitis c, multiple sclerosis.
On Mar, 9, 2014: 11,721 people who have myelodysplastic syndrome are studied. Among them, 103 (0.88%) have Enlarged Spleen. They amount to 0.27% of all the 37,659 people who have Enlarged Spleen.
Gender of people who have myelodysplastic syndrome and experienced Enlarged spleen * :
|Enlarged spleen||36.36%||63.64% |
Age of people who have myelodysplastic syndrome and experienced Enlarged spleen * :
|Enlarged spleen||1.92%||0.00%||0.96%||0.00%||0.00%||0.96%||15.38%||80.77% |
Severity of the symptom * :
Top co-existing conditions for these people * :
- Iron overload (8 people, 7.77%)
- Pain (6 people, 5.83%)
- Hypertension (5 people, 4.85%)
- Idiopathic thrombocytopenic purpura (5 people, 4.85%)
- Hyperuricaemia (3 people, 2.91%)
- Prophylaxis (3 people, 2.91%)
- Dyspepsia (3 people, 2.91%)
- Clostridial infection (3 people, 2.91%)
- Diarrhoea (3 people, 2.91%)
- Hypokalaemia (3 people, 2.91%)
Most common drugs used by these people * :
- Exjade (41 people, 39.81%)
- Revlimid (28 people, 27.18%)
- Neupogen (21 people, 20.39%)
- Thalomid (16 people, 15.53%)
- Aranesp (15 people, 14.56%)
- Allopurinol (14 people, 13.59%)
- Aspirin (14 people, 13.59%)
- Lasix (13 people, 12.62%)
- Acyclovir (11 people, 10.68%)
- Hydrea (11 people, 10.68%)
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Related topic: Myelodysplastic syndrome, Enlarged spleen
You can also:
Common treatments for Myelodysplastic Syndrome and their efficacy:
Could your drug cause it?
Browse all Myelodysplastic syndrome symptoms from A to Z:
Comments from related studies:
From this study (3 months ago):
JHeath on Dec, 18, 2013:
Black Male, 65 years old. I started out taken Carvedilol 25 mg tablet zyd, 1 tablet 2 times a day. I developed a enlarge spleen, and I cut my dosage down to half a tablet once a day. I'm also taken 2 other blood pressure pills and a baby asprine.
From this study (6 months ago):
Enlarged Spleen, uncomfortable feeling in the spleen area, goes away when I sleep, and it doesn't hurt or feel uncomfortable all day long, just sporadic pain.
Post a new comment OR Read more comments
Can you answer these questions (what is this?):
More questions for: Myelodysplastic syndrome, Enlarged spleen
You may be interested at these reviews (what is this?):
- Why was this drug not tested for people with anemia problems?
My husband has had myelodysplastic syndrome diagnosed in 2004. In 2010, his HGB went down to 10.2. RBC 3.00. He was right next to treatment when the HGB went to 10. For some unknown reason, his blood counts improved. By June 2013, his HGB was 11.9, RBC 33.9 8/3/13 he was found to have a 75% bl ...
More reviews for: Myelodysplastic syndrome, Enlarged spleen
Related drug studies for: Myelodysplastic syndrome, Enlarged spleen
Recent Myelodysplastic Syndrome related drug comparison:
More related comparison studies for: Myelodysplastic syndrome, Enlarged spleen
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.